Search:
The Brattle Group
About Brattle Areas of Expertise Experts Publications News & Events Careers Contact Us
cambridge sanfran washington brussels london madrid

Pharmaceuticals, Medical Devices, and Biotechnology

The Brattle Group uses tools of economic science to address questions in the pharmaceutical, medical device, and biotechnology industries and we provide expert testimony based on objective analysis to our clients. We offer a combination of financial and economic analysis, sensitivity to underlying medicine and science, and practical experience in medical technology markets, industries, and regulation. We apply strict standards concerning the transparency of our methodology, the intellectual rigor of our economic analysis, and the clarity of our presentation.

Our Focus

The Brattle Group offers a range of services spanning dispute- and business-related topics. Our dispute-related services typically involve the valuation of damages associated with litigation, while our business-related services include strategic evaluations and positioning our clients to take advantage of opportunities in the marketplace.
Dispute-Related Services
Antitrust & Price Fixing
Contract Disputes
Patent & Intellectual Property
Product Liability & Insurance Valuation
Clinical Development Disputes
Business-Related Services
Market Research
Pharmacoeconomics
Pricing
Regulation
Reimbursement

See Also

 
 

Related Experts

Principals:
Gregory A. Brusseau
Gayle S. Koch
Daniel L. McFadden
Stewart C. Myers
Kevin Neels
Robert J. Reynolds
Robert W. Wilson

Senior Advisors:
Henry G. Grabowski

Senior Consultants:
Lisa J. Cameron

Selected Publications

Surplus Allocations for Insurance Companies
R & D Accounting and the Tradeoff Between Relevance and Objectivity: A Pharmaceutical Industry Simulation
Financial Model of Investment in R & D
Discounting Rules for Risky Assets
Returns to Investors and the Cost of Capital for Pharmaceutical R&D
A Life-Cycle Financial Model of Pharmaceutical R&D
Measuring Pharmaceutical Industry Risk and the Cost of Capital